Bio-Techne Corp. buy Citigroup Inc.
Start price
04.02.26
/
50%
€58.50
Target price
04.02.27
-
Performance (%)
6.56%
Price
25.06.26
€62.18
Summary
This prediction is currently active. With a performance of 6.56%, the BUY prediction by Citigroup_Inc_ for Bio-Techne Corp. is trending in the right direction. Dividends of €0.16 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | 22.885% | 22.885% |
| iShares Core DAX® | -0.318% | -0.464% |
| iShares Nasdaq 100 | -0.378% | 1.358% |
| iShares Nikkei 225® | -0.907% | 9.389% |
| iShares S&P 500 | 0.437% | 0.810% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for TECH provided by MarketBeat